Dionis Therapeutics

Biotechnology Research • Concord, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	Concord, Massachusetts, United States
NAICS	541714
Keywords	Cancer Immunotherapy, Oncology, Patient-Specific Immunotherapy
Founded	2022
Employees	1-10
Socials

Key Contact at Dionis Therapeutics

Ed Fritsch

Founder and President

About Dionis Therapeutics

The multi-step process required to discover and produce a personal neoantigen vaccine for a given patient is time consuming, costly, and inevitably restricted to targeting only a small subset of imperfectly predicted neoantigens, features which limit the therapeutic potential of the current generation of personal neoantigen cancer vaccines. Dionis Therapeutics seeks to revolutionize the personal cancer vaccine space by utilizing a proprietary approach.

Dionis Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Dionis Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Dionis Therapeutics has never raised funding before.

Frequently asked questions

Dionis Therapeutics is located in Concord, Massachusetts, US.

Dionis Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Dionis Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Dionis Therapeutics

Ed Fritsch

Founder and President

4.8

40,000 users